NCT03493789 2023-10-18
Fludeoxyglucose F-18-PET in Planning Lung Cancer Radiation Therapy
Emory University
Phase 1 Completed
Clinical Trials
3 trialsNCT00864110 2013-03-22
Pharmacokinetic and Radiation Dosimetry Study Evaluating 99m TC-EC-DG SPECT/CT in Patients With Non-small Cell Lung Cancer (NSCLC)
Cell>Point LLC
Phase 1 Completed
NCT01017133 2012-09-26
Fluorine F18-EF5 and Fludeoxyglucose F18 Positron Emission Tomography in Assessing Hypoxia and Glycolysis in Patients With Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer
Abramson Cancer Center at Penn Medicine
Phase 1 Completed